KOMBIGLYZE XR 5MG/500MG TABLET (Saxagliptin Metformin) Guide
KOMBIGLYZE XR 5MG/500MG TABLET contains Saxagliptin 5mg and Metformin 500mg, an extended-release diabetes medicine prescribed to improve blood sugar control in adults with Type 2 Diabetes.
KOMBIGLYZE XR 5MG/500MG TABLET
KOMBIGLYZE XR 5MG/500MG TABLET (Saxagliptin 5mg + Metformin 500mg): Comprehensive Guide and Benefits
Introduction to KOMBIGLYZE XR 5MG/500MG TABLET (Saxagliptin 5mg + Metformin 500mg)
KOMBIGLYZE XR 5MG/500MG TABLET: A DPP-4 Inhibitor + Biguanide Combination Antidiabetic Medicine
KOMBIGLYZE XR 5MG/500MG TABLET is a prescription Diabetes Medication containing a combination of Saxagliptin 5mg and Metformin Hydrochloride Extended Release 500mg. It belongs to the drug class Dipeptidyl Peptidase-4 (DPP-4) Inhibitor + Biguanide Combination Therapy and is prescribed for improving blood glucose control in adults with Type 2 Diabetes Mellitus along with diet and exercise. (1mg)
KOMBIGLYZE XR 5MG/500MG TABLET combines two medicines with complementary mechanisms. Saxagliptin helps regulate insulin release by increasing incretin hormone activity, while Metformin reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation allows gradual release of Metformin and should be used under medical supervision. (Apollo Pharmacy)
Key Benefits of KOMBIGLYZE XR 5MG/500MG TABLET (Saxagliptin 5mg + Metformin 500mg)
Helps improve blood glucose control in adults with Type 2 Diabetes Mellitus.
Supports better fasting and post-meal blood sugar regulation.
Enhances insulin response through incretin pathway support.
Helps reduce excess glucose production by the liver.
Provides a convenient combination therapy option in a single tablet.
How KOMBIGLYZE XR 5MG/500MG TABLET (Saxagliptin 5mg + Metformin 500mg) Works
KOMBIGLYZE XR 5MG/500MG TABLET contains Saxagliptin and Metformin, which work through different pathways to improve glycaemic control. Saxagliptin inhibits the enzyme Dipeptidyl Peptidase-4 (DPP-4), preventing the breakdown of incretin hormones such as GLP-1 and GIP. This enhances glucose-dependent insulin release and reduces glucagon secretion. Metformin, a biguanide, decreases hepatic glucose production, improves insulin sensitivity, and reduces intestinal glucose absorption. Together, these actions help maintain healthier blood glucose levels.
Usage Instructions for KOMBIGLYZE XR 5MG/500MG TABLET (Saxagliptin 5mg + Metformin 500mg)
Take KOMBIGLYZE XR 5MG/500MG TABLET exactly as prescribed by your doctor.
Swallow the tablet whole with water; do not crush, chew, or break the extended-release tablet.
Take the medicine with food, usually as advised by your healthcare provider.
Monitor blood glucose levels regularly as recommended.
Do not change the dose or discontinue treatment without medical advice.
Medicinal Advantages of KOMBIGLYZE XR 5MG/500MG TABLET (Saxagliptin 5mg + Metformin 500mg)
Provides dual-action glucose control through two complementary mechanisms.
Helps improve insulin regulation after meals.
Supports reduction of excess glucose production in the liver.
Helps improve insulin sensitivity in individuals with Type 2 Diabetes.
Provides extended-release Metformin delivery for sustained action.
NOTE: KOMBIGLYZE XR 5MG/500MG TABLET is a prescription-only medicine. It should be used under medical supervision. Doctors may monitor blood glucose levels, kidney function, and overall diabetes control during treatment. It is not indicated for Type 1 diabetes or diabetic ketoacidosis. (NDMCTSGH)
Off-Label Uses of KOMBIGLYZE XR 5MG/500MG TABLET (Saxagliptin 5mg + Metformin 500mg)
Saxagliptin and Metformin combinations may sometimes be evaluated for conditions outside approved indications based on specialist judgement and available evidence.
Physician-guided management of selected metabolic disorders.
Specialist-directed approaches for insulin resistance-related conditions.
Individualised glucose management strategies in specific patient groups.
Disclaimer: Off-label uses should only occur under physician supervision and may not be approved in all countries.
Expert Advice for Optimal Use
Take KOMBIGLYZE XR 5MG/500MG TABLET regularly as prescribed.
Maintain a balanced diabetes-friendly diet and exercise routine.
Monitor blood sugar levels according to your doctor’s advice.
Inform your doctor about kidney problems or other medical conditions.
Attend regular diabetes check-ups and laboratory evaluations.
Avoid missing doses and do not double the dose after a missed tablet.
Precautions
Cardiovascular Health
Patients with heart conditions should inform their doctor before starting treatment. Regular monitoring may be recommended based on individual cardiovascular risk factors.
Liver & Kidney Function
Kidney function assessment is important before and during Metformin therapy. Patients with kidney impairment, liver disease, or conditions affecting metabolism should consult their doctor before use.
Pregnancy & Breastfeeding
Pregnant or breastfeeding women should use KOMBIGLYZE XR 5MG/500MG TABLET only after consultation with a healthcare professional to evaluate benefits and risks.
Drug Interactions
Inform your doctor about all medicines being taken, especially other diabetes medicines, insulin, contrast dye procedures, and medicines that may affect kidney function or blood glucose levels.
Existing Medical Conditions
Patients with kidney disease, metabolic disorders, pancreatitis history, dehydration, or severe infections should discuss their medical history before starting treatment.
Storage Instructions
Store below 30°C in a dry place. (1mg)
Keep tablets in the original packaging.
Protect from moisture and direct sunlight.
Keep away from children.
Do not use after the expiry date mentioned on the pack.
Frequently Asked Questions (FAQs)
Q: What is KOMBIGLYZE XR 5MG/500MG TABLET used for?
A: KOMBIGLYZE XR 5MG/500MG TABLET is used to improve blood sugar control in adults with Type 2 Diabetes Mellitus along with diet and exercise. (Apollo Pharmacy)
Q: What are the active ingredients in KOMBIGLYZE XR 5MG/500MG TABLET?
A: It contains Saxagliptin 5mg and Metformin Hydrochloride Extended Release 500mg. (1mg)
Q: What type of medicine is KOMBIGLYZE XR 5MG/500MG TABLET?
A: It is a combination antidiabetic medicine containing a DPP-4 inhibitor and a biguanide.
Q: How does KOMBIGLYZE XR 5MG/500MG TABLET work?
A: Saxagliptin improves incretin activity, while Metformin reduces liver glucose production and improves insulin sensitivity.
Q: Can KOMBIGLYZE XR 5MG/500MG TABLET be stopped suddenly?
A: Do not stop this medicine without consulting your doctor, as blood sugar control may worsen.
Q: How should KOMBIGLYZE XR 5MG/500MG TABLET be taken?
A: It should be taken exactly as prescribed, usually with food, and swallowed whole without crushing or chewing. (1mg)
Q: Who should consult a doctor before taking KOMBIGLYZE XR 5MG/500MG TABLET?
A: Patients with kidney problems, liver disease, pregnancy, breastfeeding, pancreatitis history, or those taking other diabetes medicines should consult their doctor before use.
Product Tags
KOMBIGLYZE XR 5MG/500MG TABLET, KOMBIGLYZE XR TABLET, Saxagliptin 5mg, Metformin 500mg, Saxagliptin Metformin tablet, DPP-4 inhibitor medicine, Biguanide antidiabetic medicine, Type 2 diabetes medicine, diabetes control tablet, blood sugar management medicine, extended release diabetes tablet, oral antidiabetic medicine, AstraZeneca KOMBIGLYZE XR, prescription diabetes medicine, glycemic control therapy, diabetic care tablet, insulin sensitivity medicine, glucose lowering medicine, metabolic disorder treatment, diabetes management therapy
